Clinical Trial Update: A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating BTX-A51 in patients with advanced solid tumors and metastatic breast cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• BTX-A51

Snippet

Sponsor: Edgewood Oncology Inc. | Conditions: Advanced Solid Tumor, Metastatic Breast Cancer | Phase 1 | Status: RECRUITING